GPNMB and Parkinson disease: Elevated levels of glycoprotein non-metastatic melanoma protein B (GPNMB) have been observed in the blood of patients with PD and its expression is correlated with disease severity, suggesting that GPNMB may serve as a biomarker for PD progression (Smith and Schapira, 2022).